Alfresa Holdings | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Alfresa Holdings
FDA

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

Contact Supplier

pharmacompass-1-m-2026-04-20

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Contact Supplier

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

pharmacompass-2-m-2026-04-20

Alfresa Holdings

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 2 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
2 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

4 All APIs, 4 JDMF

4 All APIs
4 JDMF

INSPECTIONS & REGISTRATIONS

4 FDA

4 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

4 All

01 4Alfresa Fine Chemical Corporation

filter District Decision Reset all filters

4 All

01 4Voluntary Action Indicated

filter Inspection End Date Reset all filters

4 All

01 12019-02-08

02 12016-04-08

03 12014-06-06

04 12009-07-30

filter City Reset all filters

4 All

01 4Akita

filter Country/Area Reset all filters

4 All

01 4Japan

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-02-08

Alfresa Holdings

City : Akita

State :

Country/Area : Japan

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-02-08

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-04-08

Alfresa Holdings

City : Akita

State :

Country/Area : Japan

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-04-08

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2014-06-06

Alfresa Holdings

City : Akita

State :

Country/Area : Japan

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2014-06-06

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

FDA Audited

USA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2009-07-30

Alfresa Holdings

City : Akita

State :

Country/Area : Japan

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2009-07-30

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact Alfresa Holdings and get a quotation

Alfresa Holdings is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find Carbocisteine bulk with JDMF offered by Alfresa Holdings

Find Levofloxacin bulk with JDMF offered by Alfresa Holdings

Find Ofloxacin bulk with JDMF offered by Alfresa Holdings

Find Pantethine bulk with JDMF offered by Alfresa Holdings

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.